We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The National IHR Focal Point of South Sudan notified WHO of an outbreak of haemorrhagic fever syndrome that was first identified in December 2015.
As of 9 May 2016, a total of 51 suspected cases, including 10 deaths, have been reported. The suspected cases were identified in the county of Aweil North (45 cases, 10 deaths) and the county of Aweil West (6 cases). The majority of suspected cases are under 20 years of age.
Symptoms of the illness have not been severe and include: unexplained bleeding, fever, fatigue, headache and vomiting. The symptoms tend to resolve quickly with supportive treatment. Currently, there is no evidence of person-to-person transmission.
Thirty three laboratory samples were tested in Uganda, Senegal and South Africa. All samples were negative for Crimean-Congo haemorrhagic fever, Ebola virus disease, Marburg virus disease, Rift Valley fever, yellow fever, West Nile virus and Zika virus; 5 samples tested positive for Onyong-nyong virus; 3 samples were positive for Chikungunya; and 1 sample tested positive for dengue virus. Further laboratory testing continues to identify the causative agent.
The area where the outbreak is occurring in South Sudan borders Darfur in Sudan where at least 469 cases of undiagnosed viral haemorrhagic fever, including 120 deaths, were reported between August and November 2015.
(Via WHO Disease Outbreak News - accessed 23/05/16)
